Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and …
Over the last 12 months, insiders at Nevro Corp. have bought $0 and sold $0 worth of Nevro Corp. stock.
On average, over the past 5 years, insiders at Nevro Corp. have bought $1.14M and sold $20.75M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,500 shares for transaction amount of $171,633 was made by McCormick Shawn (director) on 2023‑06‑07.
2023-06-07 | director | 7,500 0.0209% | $22.88 | $171,633 | -24.78% | |||
2022-05-09 | General Counsel | 2,250 0.0065% | $44.50 | $100,126 | -4.90% | |||
2022-03-11 | General Counsel | 1,500 0.0043% | $64.04 | $96,067 | -31.50% | |||
2022-03-08 | Chairman, President & CEO | 3,200 0.0089% | $63.59 | $203,488 | -32.38% | |||
2021-12-14 | director | 2,400 0.0069% | $83.78 | $201,070 | -42.69% | |||
2021-11-22 | director | 20,000 0.0577% | $85.33 | $1.71M | -42.12% | |||
2021-11-11 | General Counsel | 2,000 0.006% | $101.05 | $202,100 | -47.57% | |||
2021-08-13 | Chairman, President & CEO | 7,000 0.0207% | $105.07 | $735,490 | -28.39% | |||
2021-06-22 | Sale | director | 6,445 0.0186% | $179.03 | $1.15M | -51.46% | ||
2021-05-24 | Sale | director | 482 0.0014% | $149.65 | $72,131 | -38.06% | ||
2021-03-10 | Sale | Chief Commercial Officer | 750 0.0022% | $148.08 | $111,060 | -18.14% | ||
2021-03-01 | Sale | director | 5,303 0.0151% | $167.84 | $890,039 | -28.62% | ||
2021-02-10 | Sale | Chief Commercial Officer | 750 0.0022% | $182.55 | $136,913 | -31.59% | ||
2021-01-11 | Sale | Chief Commercial Officer | 750 0.0022% | $169.80 | $127,350 | -14.71% | ||
2020-12-10 | Sale | Chief Commercial Officer | 750 0.0021% | $161.21 | $120,910 | -10.56% | ||
2020-11-10 | Sale | Chief Commercial Officer | 750 0.0022% | $170.75 | $128,063 | -10.19% | ||
2020-10-22 | Sale | Chief Commercial Officer | 1,817 0.0054% | $165.00 | $299,805 | -5.39% | ||
2020-10-19 | Sale | Chief Commercial Officer | 1,000 0.003% | $155.00 | $155,000 | +1.72% | ||
2020-10-13 | Sale | Chief Commercial Officer | 750 0.0022% | $151.47 | $113,603 | +1.22% | ||
2020-10-12 | Sale | director | 903 0.0026% | $151.21 | $136,543 | +1.31% |
Novo A/S | 10 percent owner | 2194841 5.8869% | $5.80 | 1 | 0 | +85.38% |
JOHNSON & JOHNSON | 10 percent owner | 2066740 5.5434% | $5.80 | 1 | 1 | +85.38% |
GROSSMAN D KEITH | Chairman, President & CEO | 169290 0.4541% | $5.80 | 2 | 0 | <0.0001% |
Rashid Kashif | General Counsel | 53526 0.1436% | $5.80 | 3 | 0 | <0.0001% |
WEATHERMAN ELIZABETH H | director | 38328 0.1028% | $5.80 | 3 | 0 | +32.35% |
Armistice Capital Llc | $52.33M | 9.87 | 3.62M | +14.11% | +$6.47M | 0.17 | |
BlackRock | $49.3M | 9.3 | 3.41M | +1.2% | +$583,765.90 | <0.01 | |
The Vanguard Group | $45.83M | 8.64 | 3.17M | -21.96% | -$12.9M | <0.01 | |
Arrowmark Colorado Holdings Llc | $40.37M | 7.61 | 2.8M | -7.15% | -$3.11M | 0.1 | |
Alger | $30.09M | 5.67 | 2.08M | -1.68% | -$513,760.76 | 0.15 |